Login / Signup

Carbamazepine, phenytoin, and oral anticoagulants: Drug-drug interaction and clinical events in a retrospective cohort.

Matteo CandeloroJohn William EikelboomNoel C ChanVinai BhagirathJames D DouketisSam Schulman
Published in: Research and practice in thrombosis and haemostasis (2022)
There was a high incidence of thromboembolism in patients cotreated with anticoagulants and carbamazepine or phenytoin. The incidence rates of thrombotic and bleeding events were similar between VKA and DOAC patients. DOAC levels were lower than expected in 47% of cases tested, without correlation with clinical outcomes.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • atrial fibrillation
  • risk factors
  • emergency department
  • patient reported outcomes
  • direct oral anticoagulants